Description
AOD9604 | Modified Growth Hormone Fragment 176-191 – Research Peptide
AOD9604 is a synthetic peptide corresponding to the C-terminal 176-191 fragment of human growth hormone with an added N-terminal tyrosine residue. It lacks the receptor-binding regions responsible for the full hormone’s growth-promoting signaling.
In vitro research has examined its effects on lipolytic and lipogenic enzyme activity in adipocyte models, and has confirmed that it does not activate the growth hormone receptor or alter IGF-1 expression in these systems.
Common research applications: adipocyte metabolism research, growth hormone fragment structure-function studies, and lipid pathway assays.
Specifications
| Compound | AOD9604 |
|---|---|
| Quantity | 5mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Other AOD9604 sizes: 10mg
Frequently Asked Questions
What is AOD9604?
AOD9604 is the C-terminal 176-191 fragment of human growth hormone with an added N-terminal tyrosine, lacking the hormone’s receptor-binding regions.
What is AOD9604 studied for?
Research applications include adipocyte metabolism, lipolytic and lipogenic enzyme activity, and growth hormone fragment structure-function. All work is laboratory research only.
What purity is AOD9604 5mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
Is AOD9604 available in other sizes?
Yes. AOD9604 is also available as AOD9604 10mg.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
Reviews
There are no reviews yet.